
In the late 1990s our founding scientists Professors Mike Murphy and Robin Smith set out to solve a major issue affecting human health. Their theory? That a targeted antioxidant molecule could overcome this issue at the very place where it happens, deep inside cells.

A Breakthrough in Cellular Research
MitoQ’s origins can be traced to the work of Professors Murphy and Smith at the University of Otago in New Zealand. Their research focused on antioxidants and how they could be better utilised within the body. This led to the development of a unique molecule designed to be absorbed directly into mitochondria, the energy-producing structures within cells.
This breakthrough was an early advancement in the field of targeted molecules, an area of research that continues to develop within the study of cellular health.
A Commitment to Scientific Research
Over $60 million has been invested in independent scientific research exploring MitoQ in relation to various aspects of human health, including cardiovascular, neurological, immune, and metabolic systems. MitoQ supports open and independent scientific inquiry by providing product donations for research studies without conditions.
The MitoQ product development team continues to explore new areas of cellular health, aiming to contribute to ongoing research in the field.
A New Zealand-Based Company
MitoQ was developed in New Zealand and remains headquartered in Auckland, near the Waitematā Harbour. The company embraces a culture of curiosity, collaboration, and innovation, reflecting its Kiwi roots.
Are you a health practitioner who would like to access these products?
If you are a patient and would like to access these products, use our map to find your local Practitioner.